ContextVision AB - Asset Resilience Ratio
ContextVision AB (CONTX) has an Asset Resilience Ratio of 55.93% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of ContextVision AB for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2024)
This chart shows how ContextVision AB's Asset Resilience Ratio has changed over time. See CONTX total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down ContextVision AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CONTX company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr70.64 Million | 55.93% |
| Short-term Investments | Nkr0.00 | 0% |
| Total Liquid Assets | Nkr70.64 Million | 55.93% |
Asset Resilience Insights
- Very High Liquidity: ContextVision AB maintains exceptional liquid asset reserves at 55.93% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
ContextVision AB Industry Peers by Asset Resilience Ratio
Compare ContextVision AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Longmaster Information Tech
SHE:300288 |
Health Information Services | 0.68% |
|
Echoiq Ltd
AU:EIQ |
Health Information Services | 11.12% |
|
ARTRYA Ltd
AU:AYA |
Health Information Services | 48.49% |
|
Pharmx Technologies Ltd
AU:PHX |
Health Information Services | 22.16% |
|
Intelicare Holdings Ltd
AU:ICR |
Health Information Services | 64.05% |
|
Global Health Ltd
AU:GLH |
Health Information Services | 9.84% |
|
Pro Medicus Ltd
AU:PME |
Health Information Services | 54.64% |
|
Cogstate Ltd
AU:CGS |
Health Information Services | 54.90% |
Annual Asset Resilience Ratio for ContextVision AB (2006–2024)
The table below shows the annual Asset Resilience Ratio data for ContextVision AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 57.09% | Nkr74.37 Million ≈ $7.83 Million |
Nkr130.26 Million ≈ $13.71 Million |
-0.25pp |
| 2023-12-31 | 57.35% | Nkr59.16 Million ≈ $6.23 Million |
Nkr103.16 Million ≈ $10.86 Million |
+14.52pp |
| 2022-12-31 | 42.83% | Nkr41.86 Million ≈ $4.40 Million |
Nkr97.74 Million ≈ $10.28 Million |
+19.14pp |
| 2021-12-31 | 23.69% | Nkr26.20 Million ≈ $2.76 Million |
Nkr110.63 Million ≈ $11.64 Million |
-20.04pp |
| 2020-12-31 | 43.72% | Nkr46.36 Million ≈ $4.88 Million |
Nkr106.02 Million ≈ $11.16 Million |
+4.58pp |
| 2019-12-31 | 39.14% | Nkr36.33 Million ≈ $3.82 Million |
Nkr92.81 Million ≈ $9.77 Million |
-10.24pp |
| 2018-12-31 | 49.39% | Nkr37.95 Million ≈ $3.99 Million |
Nkr76.83 Million ≈ $8.09 Million |
-1.62pp |
| 2017-12-31 | 51.00% | Nkr40.33 Million ≈ $4.24 Million |
Nkr79.07 Million ≈ $8.32 Million |
-3.11pp |
| 2016-12-31 | 54.11% | Nkr42.91 Million ≈ $4.52 Million |
Nkr79.30 Million ≈ $8.34 Million |
+54.19pp |
| 2008-12-31 | -0.07% | Nkr-50.00K ≈ $-5.26K |
Nkr67.06 Million ≈ $7.06 Million |
-39.63pp |
| 2007-12-31 | 39.56% | Nkr27.90 Million ≈ $2.94 Million |
Nkr70.53 Million ≈ $7.42 Million |
-5.86pp |
| 2006-12-31 | 45.42% | Nkr29.61 Million ≈ $3.12 Million |
Nkr65.18 Million ≈ $6.86 Million |
-- |
About ContextVision AB
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image … Read more